Mainz Biomed N.V. (MYNZ): Revenue Growth QoQ

Graphic logo of Mainz Biomed (MYNZ)

Mainz Biomed N.V. is implementing non-invasive diagnostics, reducing the volume of medical waste. The quarterly sales volume trend visualizes financial patterns, where 0.00 serves as the base parameter value. Business scalability is driven by cloud AI and the sale of ColoAlert kits. However, expansion into the US is hindered by high promotion costs, despite the possession of European patents.

MYNZ Mainz Biomed NV Quarterly Sales Growth (07/04/2022 - 03/11/2026)

Metric breakdowns and analytics for mainzbiomed.com (MYNZ)

- stock price and consensus target price:
- stock exchange capitalization data:
- cash and cash movement details:
Fundamental valuation:Mainz Biomed N.V. - MYNZ
Manufactured products of Mainz Biomed N.V.

The metric is calculated as the percentage change in sales volume for the current quarter relative to the same period last year, measuring the rate of market expansion. Against a backdrop of neutral geopolitics, Mainz Biomed N.V. demonstrates business resilience, which allows the quarterly revenue growth trend on the GURU.Markets platform to distinguish fundamental growth in cancer diagnostics from speculative optimism.